Amir K. Varkouhi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Amir K. Varkouhi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Amin Motamed Ektesabi
University of Toronto
1 shared publication - Ana Paula Teixera Monteiro
The Keenan Research Centre of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Unity Health Toronto, 30 Bond Street, Toronto, ON M5B 1W8, Canada
1 shared publication - Chirag M. Vaswani
Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, ON M5B 1W8, Canada
1 shared publication - Claudia Chimisso Dos Santos
Keenan Research Centre for Biomedical Science at St. Michael's Hospital, Toronto, ON M5B 1T8, Canada
1 shared publication - Golam Kabir
The Keenan Research Centre of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Unity Health Toronto, 30 Bond Street, Toronto, ON M5B 1W8, Canada
1 shared publication - Hajera Amatullah
The Keenan Research Centre of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Unity Health Toronto, 30 Bond Street, Toronto, ON M5B 1W8, Canada
1 shared publication
Latest Publications
- Open Access
- 24 February 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (3) , 561
DJ-1 Deficiency Protects against Sepsis-Induced Myocardial Depression
Oxidative stress is considered one of the early underlying contributors of sepsis-induced myocardial depression. DJ-1, also known as PARK7, has a well-established role as an antioxidant. We have previously shown, in a clinically relevant model of polymicrobial sepsis, DJ-1 deficiency improved survival and bacterial clearance by decreasing ROS production. In the present study, we investigated the role of DJ-1 in sepsis-induced myocardial depression. Here we compared wildtype (WT) with DJ-1 deficient mice at 24 and 48 h after cecal ligation and puncture (CLP). In WT mice, DJ-1 was increased in the myocardium post-CLP. DJ-1 deficient mice, despite enhanced inflammatory and oxidative responses, had an attenuated hypertrophic phenotype, less apoptosis, improved mitochondrial function, and autophagy, that was associated with preservation of myocardial function and improved survival compared to WT mice post-CLP. Collectively, these results identify DJ-1 as a regulator of myocardial function and as such, makes it an attractive therapeutic target in the treatment of early sepsis-induced myocardial depression.
- 24 February 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (3) , 561
Open AccessDJ-1 Deficiency Protects against Sepsis-Induced Myocardial Depression
Oxidative stress is considered one of the early underlying contributors of sepsis-induced myocardial depression. DJ-1, also known as PARK7, has a well-established role as an antioxidant. We have previously shown, in a clinically relevant model of polymicrobial sepsis, DJ-1 deficiency improved survival and bacterial clearance by decreasing ROS production. In the present study, we investigated the role of DJ-1 in sepsis-induced myocardial depression. Here we compared wildtype (WT) with DJ-1 deficient mice at 24 and 48 h after cecal ligation and puncture (CLP). In WT mice, DJ-1 was increased in the myocardium post-CLP. DJ-1 deficient mice, despite enhanced inflammatory and oxidative responses, had an attenuated hypertrophic phenotype, less apoptosis, improved mitochondrial function, and autophagy, that was associated with preservation of myocardial function and improved survival compared to WT mice post-CLP. Collectively, these results identify DJ-1 as a regulator of myocardial function and as such, makes it an attractive therapeutic target in the treatment of early sepsis-induced myocardial depression.